Aflac Incorporated (NYSE:AFL) Increases Dividend to $0.33 Per Share

Aflac Incorporated (NYSE:AFL) announced a quarterly dividend on Wednesday, November 18th, RTT News reports. Investors of record on Wednesday, February 17th will be given a dividend of 0.33 per share by the financial services provider on Monday, March 1st. This represents a $1.32 annualized dividend and a dividend yield of 3.02%. This is a positive change from Aflac’s previous quarterly dividend of $0.28.

Aflac has increased its dividend payment by 30.1% over the last three years and has raised its dividend annually for the last 38 consecutive years. Aflac has a payout ratio of 23.0% indicating that its dividend is sufficiently covered by earnings. Research analysts expect Aflac to earn $4.83 per share next year, which means the company should continue to be able to cover its $1.12 annual dividend with an expected future payout ratio of 23.2%.

AFL stock opened at $43.72 on Friday. The company has a debt-to-equity ratio of 0.24, a quick ratio of 0.06 and a current ratio of 0.06. The stock has a market cap of $30.71 billion, a P/E ratio of 6.83, a P/E/G ratio of 1.75 and a beta of 0.81. The firm has a 50 day simple moving average of $37.76 and a 200 day simple moving average of $36.71. Aflac has a 52 week low of $23.07 and a 52 week high of $55.07.

Aflac (NYSE:AFL) last posted its quarterly earnings results on Sunday, November 1st. The financial services provider reported $1.39 EPS for the quarter, topping the consensus estimate of $1.14 by $0.25. Aflac had a net margin of 21.11% and a return on equity of 12.12%. During the same quarter in the previous year, the company earned $1.16 earnings per share. Sell-side analysts predict that Aflac will post 4.93 EPS for the current year.

Several analysts recently commented on the stock. ValuEngine cut shares of Aflac from a “sell” rating to a “strong sell” rating in a report on Monday, August 3rd. Credit Suisse Group lifted their target price on shares of Aflac from $35.00 to $40.00 and gave the company a “neutral” rating in a research note on Tuesday, September 22nd. TheStreet upgraded shares of Aflac from a “c+” rating to a “b-” rating in a research note on Wednesday, October 7th. Morgan Stanley lifted their target price on shares of Aflac from $48.00 to $49.00 and gave the company an “equal weight” rating in a research note on Wednesday. Finally, SunTrust Banks reduced their target price on shares of Aflac from $44.00 to $37.00 and set a “hold” rating for the company in a research note on Thursday, July 30th. One analyst has rated the stock with a sell rating, seven have issued a hold rating and two have issued a buy rating to the company. The company presently has an average rating of “Hold” and a consensus target price of $43.63.

About Aflac

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. It operates through two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers cancer, medical, income support, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products.

Featured Article: Portfolio Manager

Dividend History for Aflac (NYSE:AFL)

Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.